CLAIM #3082 · Abbott Laboratories (ABT) · 2023Q3 earnings call · Oct 17, 2023 · due Dec 31, 2024
“Again, I feel good about our high single-digit growth forecast. I feel good about our double-digit EPS growth.”
Robert Ford · CEO
CANNOT_DETERMINE
versus commitment · official band 5 percent
Committed
high single-digit growth forecast... double-digit EPS growth
Reported
achieving results that finished at the high end of our initial guidance ranges we provided for 2024
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2023Q3 earnings call.